BRIEF-European Commission Approves Bristol-Myers Squibb's Yervoy
January 22, 2018 at 07:13 AM EST
* EUROPEAN COMMISSION APPROVES BRISTOL-MYERS SQUIBB’S YERVOY (IPILIMUMAB) FOR TREATMENT OF PEDIATRIC PATIENTS 12 YEARS AND OLDER WITH UNRESECTABLE OR METASTATIC MELANOMA
